ArticleACS chemical neuroscience2026
TEMPOL Enhances Polyethylene Glycol Axon Fusion Following Sciatic Nerve Transection in Adult Rats.
Article in ACS chemical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neuroimmune regulation of post-traumatic bone regeneration: focus on inflammatory switching and functional recovery.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurotmesis, the most severe form of peripheral nerve injury, involves complete transection and loss of motor and sensory function. Surgical repair, typically via end-to-end neurorrhaphy (NRR), is often required. A key pathological feature is Wallerian degeneration (WD) in the distal stump, which, along with slow axonal regeneration, leads to muscle atrophy and poor functional recovery. Polyethylene glycol (PEG)-mediated axonal fusion has emerged as a promising strategy to bypass WD by rapidly reconnecting severed axons and restoring conduction. Methylene blue (MB) has previously enhanced PEG-fusion outcomes. This study investigated whether TEMPOL (TMP), a potent antioxidant, could further improve PEG-fusion-mediated repair following sciatic nerve transection in rats. Adult female Lewis rats underwent unilateral sciatic nerve transection and were randomly assigned to one of three groups: end-to-end neurorrhaphy (NRR), MB-PEG-fusion (MB-fusion), or TEMPOL-PEG-fusion (TMP-fusion). Functional recovery was assessed for 8 weeks using CatWalk gait analysis (Peroneal Functional Index, PFI). Electrophysiological recordings (CMAPs) were obtained at baseline, immediately post-repair, and at 8 weeks. Histological and immunofluorescence analyses (neurofilament, S100, synaptophysin, GFAP, Iba-1) were performed to evaluate axonal integrity, Schwann cell activity, synaptic coverage, and glial response. TMP-fusion significantly improved motor recovery compared to MB-fusion and NRR. Animals treated with TMP-fusion demonstrated superior sensorimotor function by week 8 (PFI;
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.